grant

Selective Vulnerability of Dopaminergic Neurons in Drosophila

Organization LEHIGH UNIVERSITYLocation BETHLEHEM, UNITED STATESPosted 1 Aug 2025Deadline 31 Jul 2027
NIHUS FederalResearch GrantFY2025AddressBiologic ModelsBiological ModelsBrainBrain Nervous SystemCollectionDA NeuronDNA mutationDegenerative Neurologic DisordersDiseaseDisease ResistanceDisorderDopamine neuronDrosophilaDrosophila genusDysfunctionDyskinesia SyndromesEncephalonExposure toFliesFunctional disorderGeneticGenetic ChangeGenetic defectGenetic mutationHumanIndividualLabelMapsModel SystemModelingModern ManMolecularMotorMovement Disorder SyndromesMovement DisordersMutationNAC precursorNerve CellsNerve UnitNervous System Degenerative DiseasesNeural CellNeural Degenerative DiseasesNeural degenerative DisordersNeurocyteNeurodegenerative DiseasesNeurodegenerative DisordersNeurologic Degenerative ConditionsNeuronsPARK1 proteinPARK4 proteinPARK6PARK6 genePARK6 proteinPINK1PINK1 genePINK1 gene productPINK1 proteinPTEN induced kinase 1PTEN induced putative kinase 1PTEN-induced putative kinaseParalysis AgitansParkinsonParkinson DiseaseParkinson disease 6 genePathologyPhosphatase and tensin homolog induced kinase 1PhysiopathologyPopulationPrimary ParkinsonismResearchResistanceRotenoneSNCASNCA proteinSubstantia NigraSubstantia nigra structureTestingVulnerable Populationsa-syna-synucleinalpha synucleinalpha synuclein genealphaSP22asyndegenerative diseases of motor and sensory neuronsdegenerative neurological diseasesdesigndesigningdisease modeldisorder modeldopaminergic neuronflyfruit flygenome mutationgenome scalegenome-widegenomewidein vivointerestnerve cell deathnerve cell lossneurodegenerative illnessneuron cell deathneuron cell lossneuron deathneuron lossneuronalneuronal cell deathneuronal cell lossneuronal deathneuronal lossnon A-beta component of AD amyloidnon A4 component of amyloid precursorpathophysiologypreventpreventingprotein kinase BRPKprotein kinase BRPK generesistance to diseaseresistantresistant diseaseresistant to diseaseserine/threonine-protein kinase PINK1therapeutic targettooltransgene expressiontreatment strategyvulnerable groupvulnerable individualvulnerable peopleα synuclein geneα-synα-synuclein
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Full Description

Project Summary
Each major neurodegenerative disease is associated with the loss of specific populations of neurons,

yet very little is known regarding why these neurons are rendered vulnerable while others remain relatively

resistant. In Parkinson’s Disease, for example, dopaminergic neurons within the Substantia Nigra are primarily

lost while other nearby neurons remain unaffected. Understanding the mechanisms underlying this selective

vulnerability should help to generate strategies for protective these vulnerable neurons from disease. Thus far,

a major hurdle in the field has been the inability to assess the vulnerability of individually identifiable neurons in

vivo.

To address this, we have developed a proposed research plan to investigate the mechanisms

responsible for maintaining Dopaminergic (DA) neuron viability within the Drosophila brain. Our guiding

hypothesis is that conserved factors render specific populations of neurons vulnerable to Parkinson’s Disease

while others remain resistant. To test this hypothesis, we propose to study the selective vulnerability of

Drosophila DA neurons by: (1) Creating a vulnerability map of individual DA neurons in an environmental

model of Parkinson’s Disease, (2) Manipulating the vulnerability status of individual DA neurons, and (3)

Comparing vulnerability maps of different Parkinson’s Disease models.

By investigating the cellular and molecular mechanisms underlying selective neuronal vulnerability, our

proposed research has the potential to reveal why certain populations of neurons are rendered vulnerable.

Understanding the differences between vulnerable and resistant neurons is critical for identifying potential

therapeutic targets and developing strategies to help maintain vulnerable neurons and increase their

resistance to disease.

Grant Number: 1R03NS144936-01
NIH Institute/Center: NIH

Principal Investigator: Daniel Babcock

Sign up free to get the apply link, save to pipeline, and set email alerts.

Sign up free →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →